Greenleaf Trust Sells 932 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Greenleaf Trust trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,458 shares of the medical equipment provider's stock after selling 932 shares during the quarter. Greenleaf Trust's holdings in Intuitive Surgical were worth $13,104,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the stock. AlphaCore Capital LLC grew its holdings in shares of Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after acquiring an additional 18 shares during the last quarter. Accredited Investors Inc. increased its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock worth $543,000 after acquiring an additional 19 shares in the last quarter. Second Line Capital LLC increased its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares in the last quarter. Colonial Trust Co SC increased its position in shares of Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after acquiring an additional 20 shares in the last quarter. Finally, Crown Wealth Group LLC increased its position in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after acquiring an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president directly owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Barclays lowered their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Finally, Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $592.59.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $2.08 during trading hours on Thursday, hitting $526.05. 1,423,501 shares of the company were exchanged, compared to its average volume of 1,675,429. The company has a market cap of $188.55 billion, a PE ratio of 77.13, a PEG ratio of 5.60 and a beta of 1.64. The firm's 50 day moving average is $538.20 and its 200-day moving average is $536.86. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the company posted $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.